Eight months after Sanofi’s…
Eight months after Sanofi’s former Chief Medical Officer, Dietmar Berger, [...]
Regeneron has reported a phase 3…
Regeneron has reported a phase 3 win in generalized myasthenia [...]
Another cell therapy biotech has…
Another cell therapy biotech has run out of steam, this [...]
Akeso is adding a pair of…
Akeso is adding a pair of late-stage wins to its [...]
Amid a frozen-over IPO landscape,…
Amid a frozen-over IPO landscape, LB Pharmaceuticals has filed to [...]
The Supreme Court is allowing the…
The Supreme Court is allowing the Trump administration to axe [...]
Arena BioWorks has laid off 30% of…
Arena BioWorks has laid off 30% of its workers 19 [...]
Lighthouse Pharmaceuticals’ plan…
Lighthouse Pharmaceuticals’ plan to become a beacon of hope for [...]
The Cleveland Clinic’s Nathan…
The Cleveland Clinic’s Nathan Pennell, M.D., Ph.D., is switching to [...]
The FDA’s recent rebuff of…
The FDA’s recent rebuff of Replimune’s melanoma candidate has rippled [...]